跳至主要内容
临床试验/NCT07783165
NCT07783165尚未招募不适用

Patient Study to Evaluate the Safety and Emollient Performance of Doublebase Once in the Treatment of Ichthyosis

Dermal Laboratories Ltd0 个研究点目标入组 100 人开始时间: 2026年9月7日最近更新:
适应症
干预措施

试验速览

阶段
不适用
状态
尚未招募
入组人数
100
主要终点
Questionnaire responses

研究概览

简要总结

28 Day Survey study in patients with Ichthyosis

详细描述

Ichthyosis patients registered on the ISG/MHF database or patients responding to information on the websites will be advised about the study and asked if they maybe interested in trying Doublebase Once. Any patients interested in taking part will then be asked to register, by completing a short questionnaire that will be used as a pre-screen tool to exclude any patients who are ineligible for the study.

Patients will then be provided with the Patient Information Sheet (PIS) to read and then complete a consent questionnaire confirming their agreement to participate in the study. Once consent has been obtained, patients will then complete a screening questionnaire. ISG/MHF and the Sponsor will require access to personal information such as email addresses (for sending the questionnaires and safety monitoring) and home addresses (for sending the packs of Doublebase Once), but these details will be used solely for the purpose of the study.

If all screening questions are completed and the patient is eligible in accordance with the inclusion and exclusion criteria, the patient will then be sent two pump packs of Doublebase Once 500g.

On receipt of their pack(s) of Doublebase Once (Day 0), the patients will be asked to read through all the information provided and to complete an online questionnaire and, if they agreed at consent, they will be asked to photograph one area of their ichthyosis that will be treated with the product and upload to the database alongside their questionnaire. Guidance on taking the photos will be provided in the questionnaire with regards to, lighting, location, distance, angle of taking photographs and background. This questionnaire and image(s) will form the baseline 'before using Doublebase Once' and there will be some questions to be completed immediately after first use of the product.

Patients will then be asked to use Doublebase Once, as per the package leaflet for approximately 4 weeks, once daily (unless they need to use it more often) and on one area affected by ichthyosis, instead of their usual leave-on emollient. If, during the study patients find that they like using Doublebase Once, they can use the product on all affected areas. Patients will also be asked to use Doublebase Once instead of their usual wash product. If patients do not want to use Doublebase Once instead of their usual wash products, they will be asked to continue to use their usual products.

研究设计

研究类型
Interventional
分配方式
Na
干预模型
Single Group
主要目的
Treatment
盲法
None

入排标准

性别
All
接受健康志愿者

入选标准

  • Patients with ichthyosis of any severity previously diagnosed by a Healthcare Professional (HCP).
  • Patients normally managing their skin condition by regular and ongoing use of leave-on emollient(s).
  • Patients willing to use Doublebase Once for one month, instead of the patients usual emollient, as part of their normal ichthyosis management for the area(s) they have selected to treat for the study? This would also involve trying to use it once daily only

排除标准

  • Does not regularly use an emollient
  • Known history of intolerance or skin sensitivity to any of the ingredients of Doublebase Once (as identified on the Patient Information Sheet and product labelling), or similar products used.
  • Currently participating in a study involving an investigational medicinal product/medical device or having participated in the previous 30 days.
  • Patients currently residing in Northern Ireland (this is due to the different approval process).
  • Patients (or their parents/legal guardians, in the case of infants, very young children or adolescent adults) who may have difficulties completing the feedback questionnaires, which will be written in English only.
  • Employees of the Sponsor (Dermal or the Diomed group companies), or any immediate family member (partner, offspring, parents, siblings or sibling's offspring) of such employees

研究组 & 干预措施

single arm study in approximately 100 Ichthyosis patients of any age.

Experimental

Open label

干预措施: Doublebase Once (Device)

结局指标

主要结局

Questionnaire responses

时间窗: 4 weeks

Skin condition changes from baseline parameters scores 0-10 (0 = strongly agree, 10 = Strongly disagree) and product use questionnaires

次要结局

未报告次要终点

研究者

申办方类型
Industry
责任方
Sponsor

相似试验